Estriol (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Estriol" in Galician language version.

refsWebsite

Global rank Galician rank

4^th place

6^th place

2^nd place

7^th place

1chemspider.com

8,573^rd place

681^st place

5,849^th place

619^th place

6^th place

8^th place

719^th place

690^th place

1web.archive.org

1^st place

1^st place

1sigmamenopause.com

low place

low place

archive.org

Raju U, Bradlow HL, Levitz M (1990). "Estriol-3-sulfate in human breast cyst fluid. Concentrations, possible origin, and physiologic implications". Ann. N. Y. Acad. Sci. 586: 83–7. PMID 2141460. doi:10.1111/j.1749-6632.1990.tb17793.x.

chemspider.com

ChemSpider Estriol

doi.org

dx.doi.org

Raju U, Bradlow HL, Levitz M (1990). "Estriol-3-sulfate in human breast cyst fluid. Concentrations, possible origin, and physiologic implications". Ann. N. Y. Acad. Sci. 586: 83–7. PMID 2141460. doi:10.1111/j.1749-6632.1990.tb17793.x.
Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (2002). "Treatment of multiple sclerosis with the pregnancy hormone estriol". Ann. Neurol. 52 (4): 421–8. PMID 12325070. doi:10.1002/ana.10301.
Melamed M, Castaño E, Notides AC, Sasson S (1997). "Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol". Mol. Endocrinol. 11 (12): 1868–78. PMID 9369454. doi:10.1210/me.11.12.1868.
Lappano R, Rosano C, De Marco P, De Francesco EM, Pezzi V, Maggiolini M (2010). "Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells". Mol. Cell. Endocrinol. 320 (1-2): 162–70. PMID 20138962. doi:10.1016/j.mce.2010.02.006.
Sites CK (2008). "Bioidentical hormones for menopausal therapy". Women's Health (Lond Engl) 4 (2): 163–71. PMID 19072518. doi:10.2217/17455057.4.2.163. (free subscription required)

ebi.ac.uk

CHEBI

medscape.com

Sites CK (2008). "Bioidentical hormones for menopausal therapy". Women's Health (Lond Engl) 4 (2): 163–71. PMID 19072518. doi:10.2217/17455057.4.2.163. (free subscription required)

nih.gov

ncbi.nlm.nih.gov

Raju U, Bradlow HL, Levitz M (1990). "Estriol-3-sulfate in human breast cyst fluid. Concentrations, possible origin, and physiologic implications". Ann. N. Y. Acad. Sci. 586: 83–7. PMID 2141460. doi:10.1111/j.1749-6632.1990.tb17793.x.
Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (2002). "Treatment of multiple sclerosis with the pregnancy hormone estriol". Ann. Neurol. 52 (4): 421–8. PMID 12325070. doi:10.1002/ana.10301.
Melamed M, Castaño E, Notides AC, Sasson S (1997). "Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol". Mol. Endocrinol. 11 (12): 1868–78. PMID 9369454. doi:10.1210/me.11.12.1868.
Lappano R, Rosano C, De Marco P, De Francesco EM, Pezzi V, Maggiolini M (2010). "Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells". Mol. Cell. Endocrinol. 320 (1-2): 162–70. PMID 20138962. doi:10.1016/j.mce.2010.02.006.
Sites CK (2008). "Bioidentical hormones for menopausal therapy". Women's Health (Lond Engl) 4 (2): 163–71. PMID 19072518. doi:10.2217/17455057.4.2.163. (free subscription required)

pubchem.ncbi.nlm.nih.gov

PubChem compound

sigmamenopause.com

Derzko, C (2009). "Bioidentical Hormone Therapy at Menopause" (PDF). Endocrinology Rounds 9 (6): 1–6. Arquivado dende o orixinal (pdf) o 16 de xullo de 2011. Consultado o 18 de febreiro de 2012.

web.archive.org

Derzko, C (2009). "Bioidentical Hormone Therapy at Menopause" (PDF). Endocrinology Rounds 9 (6): 1–6. Arquivado dende o orixinal (pdf) o 16 de xullo de 2011. Consultado o 18 de febreiro de 2012.